大葉大學圖書館 |

Targeting oral cancer[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.99431
書名/作者:	Targeting oral cancer/ edited by Andrew M. Fribley.
其他作者:	M. Fribley, Andrew.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	x, 302 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Mouth - Cancer.
標題:	Mouth - Cancer
標題:	Mouth - Cancer
標題:	Dentistry.
標題:	Oncology.
標題:	Oral and Maxillofacial Surgery.
ISBN:	9783319276472
ISBN:	9783319276458
內容註:	Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.
摘要、提要註:	This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.
電子資源:	http://dx.doi.org/10.1007/978-3-319-27647-2

Targeting oral cancer[electronic resource] /
Targeting oral cancer[electronic resource] /edited by Andrew M. Fribley. - Cham :Springer International Publishing :2016. - x, 302 p. :ill., digital ;24 cm.

Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.

This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.

ISBN: 9783319276472

Standard No.: 10.1007/978-3-319-27647-2doiSubjects--Topical Terms:

608905
Mouth
--Cancer.

LC Class. No.: RC280.M6

Dewey Class. No.: 616.99431

Targeting oral cancer[electronic resource] /
LDR:02745nam a2200313 a 4500 001 456836
003 DE-He213
005 20160819164941.0
006 m d
007 cr nn 008maaau
008 161227s2016 gw s 0 eng d
020 $a 9783319276472 $q (electronic bk.)
020 $a 9783319276458 $q (paper)
024 7 $a 10.1007/978-3-319-27647-2 $2 doi
035 $a 978-3-319-27647-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.M6
072 7 $a MMD $2 bicssc
072 7 $a MED016000 $2 bisacsh
082 0 4 $a 616.99431 $2 23
090 $a RC280.M6 $b T185 2016
245 0 0 $a Targeting oral cancer $h [electronic resource] / $c edited by Andrew M. Fribley.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a x, 302 p. : $b ill., digital ; $c 24 cm.
505 0 $a Epidemiology and Management: Epidemiology -- Emerging Role of HPV -- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling -- Stem Cells and Tumor Development -- Prognostic/Predictive Biomarkers -- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials -- Emerging Drug Targets -- Targeting the UPR -- Targeting Meditators of Coagulation -- Resveratrol Pre-Sensitizing -- Academic High Throughput Drug Discovery.
520 $a This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity. The text is organized into three sections covering epidemiology and management, cancer development and biomarkers, and breaking developments and novel approaches for drug discovery. The first section includes discussion of the emerging role of human papillomavirus in oral cancer and explains the surgical, chemotherapy, and radiation approaches to treatment. Aspects such as molecular progression and signaling, the role of cancer stem cells in tumor development, and the value of various biomarkers are then examined. The final section is devoted to the latest advances and covers, among other topics, current clinical trials, emerging drug targets, and targeting of the unfolded protein response and of mediators of coagulation. Recent decades have witnessed a significant increase in the number of deaths worldwide from cancers of the oral cavity, pharynx, and oropharynx. Targeting Oral Cancer will be an excellent resource for practitioners and researchers and will hopefully assist in the urgent quest to improve screening and prevention, diagnosis, and treatment approaches.
650 0 $a Mouth $x Cancer. $3 608905
650 0 $a Mouth $x Cancer $x Diagnosis. $3 607407
650 0 $a Mouth $x Cancer $x Treatment. $3 607408
650 1 4 $a Dentistry. $3 461354
650 2 4 $a Oncology. $3 205017
650 2 4 $a Oral and Maxillofacial Surgery. $3 464201
700 1 $a M. Fribley, Andrew. $3 656526
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-27647-2
950 $a Medicine (Springer-11650)